$2.29T
Total marketcap
$126.25B
Total volume
BTC 49.71%     ETH 15.80%
Dominance

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Stock

4.23 CNY {{ price }} -0.936767% {{change_pct}}%
COUNTRY
China
Exchange
Shanghai
Market Cap
7.03B CNY
LOW - HIGH [24H]
4.12 - 4.31 CNY
VOLUME [24H]
7.15M CNY
{{ volume }}
P/E Ratio
11.43
Earnings per share
0.37 CNY

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Price Chart

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Financial and Trading Overview

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong stock price 4.23 CNY
Previous Close 5.57 CNY
Open 5.55 CNY
Bid 5.52 CNY x 0
Ask 5.53 CNY x 0
Day's Range 5.5 - 5.56 CNY
52 Week Range 5.25 - 8.05 CNY
Volume 10.3M CNY
Avg. Volume 9.79M CNY
Market Cap 9.19B CNY
Beta (5Y Monthly) 0.377384
PE Ratio (TTM) 12.021739
EPS (TTM) 0.37 CNY
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date May 18, 2010
1y Target Est 7.65 CNY

600866.SS Valuation Measures

Enterprise Value 12.57B CNY
Trailing P/E 12.021739
Forward P/E 10.240741
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.52565783
Price/Book (mrq) 1.3104267
Enterprise Value/Revenue 0.719
Enterprise Value/EBITDA 4.784

Trading Information

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock Price History

Beta (5Y Monthly) 0.377384
52-Week Change -12.42%
S&P500 52-Week Change 20.43%
52 Week High 8.05 CNY
52 Week Low 5.25 CNY
50-Day Moving Average 5.67 CNY
200-Day Moving Average 6.19 CNY

600866.SS Share Statistics

Avg. Volume (3 month) 9.79M CNY
Avg. Daily Volume (10-Days) 12.87M CNY
Shares Outstanding 1.66B
Float 596.1M
Short Ratio N/A
% Held by Insiders 67.33%
% Held by Institutions 1.56%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 135:100

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 3.12%
Operating Margin (ttm) 8.20%
Gross Margin 15.36%
EBITDA Margin 15.02%

Management Effectiveness

Return on Assets (ttm) 9.45%
Return on Equity (ttm) 20.73%

Income Statement

Revenue (ttm) 17.48B CNY
Revenue Per Share (ttm) 13.27 CNY
Quarterly Revenue Growth (yoy) -0.20%
Gross Profit (ttm) 3.09B CNY
EBITDA 2.63B CNY
Net Income Avi to Common (ttm) 545.79M CNY
Diluted EPS (ttm) 0.46
Quarterly Earnings Growth (yoy) -34.20%

Balance Sheet

Total Cash (mrq) 1.42B CNY
Total Cash Per Share (mrq) 0.85 CNY
Total Debt (mrq) 4.4B CNY
Total Debt/Equity (mrq) 62.31 CNY
Current Ratio (mrq) 0.893
Book Value Per Share (mrq) 4.22

Cash Flow Statement

Operating Cash Flow (ttm) 844.56M CNY
Levered Free Cash Flow (ttm) 1.37B CNY

Profile of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

Country China
State N/A
City Zhaoqing
Address No.67 Gongnong North Road
ZIP 526040
Phone 86 75 8229 1130
Website https://www.starlake.com.cn
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 8908

Star Lake Bioscience Co., Inc. manufactures and sells pharmaceutical raw materials, and food and feed additives in China and internationally. It offers guanosine that is used as an intermediate for food and pharmaceutical raw material; L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. The company also provides disodium 5'-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5'-guanylate for canned meat, ham, salted meat, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. The company offers its products under the Star Lake and Yue Bao brands. Star Lake Bioscience Co., Inc. was founded in 1964 and is based in Zhaoqing, China.

Q&A For Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock

What is a current 600866.SS stock price?

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS stock price today per share is 4.23 CNY.

How to purchase Star Lake Bioscience Co., Inc.Zhaoqing Guangdong stock?

You can buy 600866.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong?

The stock symbol or ticker of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong is 600866.SS.

Which industry does the Star Lake Bioscience Co., Inc.Zhaoqing Guangdong company belong to?

The Star Lake Bioscience Co., Inc.Zhaoqing Guangdong industry is Biotechnology.

How many shares does Star Lake Bioscience Co., Inc.Zhaoqing Guangdong have in circulation?

The max supply of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong shares is 1.66B.

What is Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Price to Earnings Ratio (PE Ratio)?

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong PE Ratio is 11.43243200 now.

What was Star Lake Bioscience Co., Inc.Zhaoqing Guangdong earnings per share over the trailing 12 months (TTM)?

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong EPS is 0.37 CNY over the trailing 12 months.

Which sector does the Star Lake Bioscience Co., Inc.Zhaoqing Guangdong company belong to?

The Star Lake Bioscience Co., Inc.Zhaoqing Guangdong sector is Healthcare.